Judge Questions US Military's Testosterone Policy for Troops

A federal judge has ordered the Trump administration to explain a discrepancy in the US military's new testosterone policy. The policy, announced earlier this month by Defense Secretary Pete Hegseth, involves screening male service members aged 30 and above for testosterone deficiencies and offering them hormone treatment. This initiative aims to ensure these troops maintain optimal performance levels.

However, the judge's order stems from concerns that the same hormone treatment is being denied to transgender service members. The court is seeking clarification on why cisgender troops are eligible for testosterone supplementation while transgender troops are not, highlighting a potential disparity in healthcare access and policy application within the military.

The initiative to screen older soldiers for testosterone deficiencies was detailed in a statement by Hegseth. The policy's rollout has drawn attention and is now under judicial review due to the differential treatment of service members based on their gender identity. The administration is required to provide a detailed explanation for this policy distinction.